GLP-1 compounder issues recall for copycat Zepbound
BioPharma DiveJonathan GardnerOctober 22, 2026
The notice adds to growing concerns about the safety of knockoff weight loss drugs, which have remained popular despite FDA warnings and legal pressure from Eli Lilly and Novo.